![It's time to rethink peer review policies—and consider an “Earth Shot Program”](https://cdn.cancerletter.com/media/2019/07/Earth-shot-web.jpg)
![It's time to rethink peer review policies—and consider an “Earth Shot Program”](https://cdn.cancerletter.com/media/2019/07/Earth-shot-web.jpg)
Cover Story
Guest Editorial
At a recent NIH study section that I chaired, we had many applications that we reviewed as a group before the meeting. At the meeting, we were required to discuss over 50% of the grants.
By Claire Dietz and Matthew Bin Han Ong
Conversation with The Cancer Letter
By Matthew Bin Han Ong and Claire Dietz
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
NCI Trials
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
NCI Trials for July
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- “All in Her Head” catalogs the history of medicine’s atrocities against women
- CM24 combination improves clinical outcomes in advanced metastatic PDAC in phase II study interim data
- Prominent GI oncologist Axel Grothey was forced out of Mayo Clinic for unethical sexual relationships with women he mentored
Three reprimands later, he retains leadership—and mentorship—positions - Chernobyl: a 35 year follow up on long-term health effects
- How a Georgetown med school student found her calling in surgery, law, and health equity
- The unKOOL, unfiltered history of menthol cigarettes